|

Venetoclax 100 mg d1，200 mg d2，400 mg d3-14； Clinical Trials

1 actively recruiting trial

Also known as: Cytarabine 100 mg/m2，qd，d1-7, Etoposide 0.1 g，qd，d1-5, Homoharringtoine, HHT 2 mg/m2，qd，d1-7

Top Sponsors

  • Huai'an First People's Hospital1

Indications

  • Acute Myeloid Leukemia1
  • Cancer1

Other1 trial

Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.